threonine has been researched along with Epileptic Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciani, E; Cosentino, L; De Filippis, B; Fuchs, C; Fuso, A; Medici, G; Mottolese, N; Pietraforte, D; Quattrini, MC; Talamo, MC; Urbinati, C | 1 |
| Calvanese, M; Colarusso, A; Lauro, C; Parrilli, E; Tutino, ML | 1 |
2 other study(ies) available for threonine and Epileptic Syndromes
| Article | Year |
|---|---|
Treatment with FRAX486 rescues neurobehavioral and metabolic alterations in a female mouse model of CDKL5 deficiency disorder.
Topics: Animals; Disease Models, Animal; Disks Large Homolog 4 Protein; Epileptic Syndromes; Female; Glucose; Male; Mice; Mice, Knockout; p21-Activated Kinases; Protein Serine-Threonine Kinases; Pyridones; Pyrimidines; Serine; Spasms, Infantile; Threonine | 2022 |
Active human full-length CDKL5 produced in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.
Topics: Antarctic Regions; Cold Temperature; Epileptic Syndromes; Humans; Peptide Hydrolases; Protein Kinases; Protein Serine-Threonine Kinases; Proteome; Pseudoalteromonas; Recombinant Proteins; Serine; Spasms, Infantile; Threonine | 2022 |